switching from liraglutide to semaglutide dosing tirzepatide semaglutide: complete transition guide Outcomes in GLP-1 RA-Experienced Patients
Description
This intervention for individuals with obesity (BMI, 30 to 45 kg/m 2 ) and diabetes (type 1 or 2) [231] involved a hypocaloric diet and exercise, as well as a cognitive-behavioral intervention and group education
PIONEER 7 Investigators
@miawillsjourno
Farxigas weight loss mechanism is different
CONCLUSIONS CONFLICTS OF INTEREST Young Min Cho reports a grant from Sanofi and consultation fees from LG Chemical
